Vimarsana
Biggest News Aggregation in the World

Page 5 - 69404d10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 69404d10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 69404d10 Today - Breaking & Trending Today

Sumitomo Mitsui Trust Holdings Inc. Has $112.29 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Vimarsana News

Sumitomo Mitsui Trust Holdings Inc. Has $112.29 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Sumitomo Mitsui Trust Holdings Inc. trimmed its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 1.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,447,666 shares of the biotechnology company’s stock after selling 202,282 shares during […]

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Brokerages - Vimarsana News

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […]

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $11.73 Average Price Target from Brokerages - Vimarsana News

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $11.73 Average Price Target from Brokerages

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen analysts that are currently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12 month […]

Source: wkrb13.com
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Analysts - Vimarsana News

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the […]

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $12.40 Consensus Target Price from Analysts - Vimarsana News

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $12.40 Consensus Target Price from Analysts

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The […]